Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
doi: 10.1016/j.endien.2023.12.001 43 RubinoDAbrahamssonNDaviesMHesseDGreenwayFLJensenCet al
Semaglutide carries a specific warning about potential worsening of diabetic retinopathy in patients with pre-existing retinopathy, particularly with rapid improvement in glucose control
Keeping the injection site clean and dry for several hours post-injection can help minimize local reactions
Lixisenatide Monotherapy GetGoal-Mono was a 12-week, double-blind, placebo-controlled trial that randomised 361 patients with type 2 diabetes of mean duration 1.11.4 years attempting to control their diabetes with diet and exercise alone, to lixisenatide OD for 12 weeks as a one-step dose increase (10 g for 2 weeks, then 20 g) or two-step dose increase (10 g for 1 week, 15 g for 1 week, then 20 g), or placebo also with a one- or two-step increase [17]
Loprinzi et al
US$ 22.43
US$ 21.03
US$ 23.97
US$ 21.02
US$ 21.55
